Red Blood Cell Transfusion Thresholds for Improved Quality of Life for Patients Undergoing a Pancreatectomy for Pancreatic Cancer
Resectable Pancreatic Carcinoma
About this trial
This is an interventional supportive care trial for Resectable Pancreatic Carcinoma focused on measuring pancreatectomy, Transfusion
Eligibility Criteria
Inclusion Criteria: Male or female >= 18 years of age at Visit 1 Documentation of a pancreatic cancer diagnosis as evidenced by one or more clinical features meeting the following criteria: CT evidence of a mass in the pancreas consistent with cancer Tissue diagnosis of cancer either before surgery or from the resected specimen Preoperative evaluation suggestive that pancreatic resection is feasible Written informed consent (and assent when applicable) obtained from subject or subject's legal representative and ability for subject to comply with the requirements of the study Exclusion Criteria: Pregnant, breastfeeding, or unwilling to practice birth control during participation in the study Presence of a condition or abnormality that in the opinion of the Investigator would compromise the safety of the patient or the quality of the data Patients who are unable to receive or who refuse blood products Patients involved in an autologous pre-donation program Patients found to have metastatic disease upon entry into abdomen-having been randomized, these patients will be removed from the study and replaced with another patient Patients found to not have cancer during the operation- If the resected lesion proves not to be cancer, the patient will remain as an enrolled patient but not evaluable and replaced by another patient Established severe cardiovascular disease with estimated 5-year survival <10% based on Framingham risk score Unstable angina or recent myocardial infarction (MI)/stroke within 6 months
Sites / Locations
Arms of the Study
Arm 1
Arm 2
Experimental
Experimental
Arm I (Transfusion for Hgb less than 7 g/dL)
Arm II (Transfusion for Hgb less than 9 g/dL)
Patients undergo red blood cell transfusion if Hgb is less than 7 g/dL while on study. Patients undergo CT scan, x ray imaging, and blood sample collection throughout the study.
Patients undergo red blood cell transfusion if Hgb is less than 9 g/dL while on study. Patients undergo CT scan, x ray imaging, and blood sample collection throughout the study.